Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Virol. 2006 Dec;37 Suppl 1:S47-51.

Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.

Author information

1
August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Ratsupites St.1, Riga, LV-1067, Latvia. modra@latnet.lv

Abstract

BACKGROUND:

Human herpesvirus 6 (HHV-6) and 7 (HHV-7) have been suggested as possible triggering agents for chronic fatigue syndrome (CFS).

OBJECTIVES:

To determine the possible association of HHV-6 and HHV-7 infections with CFS.

STUDY DESIGN:

The prevalence of latent/persistent and active viral infections by nPCR, characteristic of HHV-6 variants using restriction endonuclease analysis and changes of lymphocyte subsets in peripheral blood by laser flow-cytometry in 17 CFS patients was examined. In addition, 12 patients with unexplained chronic fatigue and 20 blood donors (BD) were studied.

RESULTS:

No difference in prevalence of latent/persistent single viral infections between the patients and BD was found but dual infection rate was significantly higher in CFS patients. Active HHV-6 and dual (HHV-6 + HHV-7) infections were detected in CFS patients only and frequency of HHV-7 reactivation was also significantly higher in these patients. HHV-6 variant B was predominant in CFS patients (12/13). The changes of immunological parameters in CFS patients with active dual infection were characterized by significant decrease of CD3+ and CD4+ T cells, significant increase of CD95+ cells and decrease of CD4+/CD8+ ratio.

CONCLUSIONS:

HHV-6 and HHV-7 may be involved in the pathogenesis of CFS and reactivation of both viruses may provoke changes in the phenotype of circulating lymphocytes.

PMID:
17276369
DOI:
10.1016/S1386-6532(06)70011-7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center